Skip to content
Bored Studies
RecruitingAccepts healthy volunteers

The DC Cohort Longitudinal HIV Status Neutral Study

George Washington University · with National Institute of Allergy and Infectious Diseases (NIAID) · NCT01206920

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Any age listed · All sexes
Healthy volunteers
Accepted
Study type
Observational
Target enrollment
19000
US sites recruiting
14
Study start
January 2011
Record last updated
February 2, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

The goal of the DC Cohort is to establish a clinic-based city-wide longitudinal cohort that will describe clinical outcomes, and improve the quality of care for patients diagnosed with Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome (HIV/AIDS) or at higher risk for acquiring HIV and receiving care in Washington, DC.

Conditions: HIV; AIDS

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Treatment Cohort Inclusion Criteria

  • Patient is receiving care for HIV at one or more of the twelve participating clinics in the DC Cohort.
  • Patient is either age 18 years or older, or seeks HIV care independently and is able to understand and sign informed consent.
  • Patient is a minor who is consented by a parent or legal guardian.

Treatment Cohort Exclusion Criteria

  • Patient is unable or refuses to provide informed consent.
  • Minor children ages 12 through 17 who are unaware of their HIV status

Prevention Cohort Inclusion Criteria

Persons receiving any antiretroviral prescription without evidence of HIV or Hepatitis B infection

  • PrEP (e.g., TDF/FTC, Descovy, Apretude)
  • Combination ART indicative of nPEP in an HIV-uninfected person
  • Persons receiving an antiretroviral prescription indicative of DoxyPEP Doxycycline 200mg PO taken within 72 hrs of unprotected sexual encounter (or variations thereof where clearly not prescribed as a treatment course)
  • Test positive for ≥1 bacterial STI (positive gonorrhea (GC/NG) or chlamydia (CT) test or positive syphilis test requiring treatment within one year)
  • 2 bacterial STI (GC, chlamydia, syphilis) tests at 2 or more different encounters
  • 2 HIV tests at 2 or more different encounters
  • Patient requesting PrEP at their clinical visit
  • Patient requesting nPEP at their clinical visit
  • People who identify as injecting drugs

Patients with a Z29.81 Encounter for HIV pre-exposure prophylaxis

Recruiting US locations

  • Kaiser Permanente Mid-Atlantic States

    Washington D.C., DC 20002

    Site contact: Michael A Horberg, MD · 301-816-6302 · Michael.Horberg@kp.org

  • Unity Health Care

    Washington D.C., DC 20003

    Site contact: Gebeyehu Teferi, MD · GTeferi@unityhealthcare.org

  • Georgetown University

    Washington D.C., DC 20007

    Site contact: Princy Kumar, MD · Princy.N.Kumar@gunet.georgetown.edu

  • La Clinica Del Pueblo

    Washington D.C., DC 20009

    Site contact: Amina Chaudhry, MD · AChaudhry@lcdp.org

  • Whitman-Walker Health

    Washington D.C., DC 20009

    Site contact: Stephen Abbott, MD · sabbott@whitman-walker.org

  • Children's National Medical Center--Pediatric Clinic

    Washington D.C., DC 20010

    Site contact: Natella Rakhmanina, MD · NRakhman@childrensnational.org

  • Washington Hospital Center

    Washington D.C., DC 20010

    Site contact: Adam Klein, MD · Adam.J.Klein@medstar.net

  • Washington Health Institute

    Washington D.C., DC 20017

    Site contact: Jose Bordon, MD, PhD · 202-525-5175 · jbordon@dc-whi.org

  • Family and Medical Counseling Service

    Washington D.C., DC 20020

    Site contact: Angela Wood · afulwood@fmcsinc.org

  • George Washington Medical Faculty Associates

    Washington D.C., DC 20037

    Site contact: Maria Elena Ruiz, MD · mruiz@mfa.gwu.edu

  • Howard University Hospital--Adult Clinic

    Washington D.C., DC 20060

    Site contact: Jhansi Gajjala, MD · jhansi.gajjala@howard.edu

  • Howard University Hospital--Pediatric Clinic

    Washington D.C., DC 20060

    Site contact: Sohail Rana, MD · srana@howard.edu

  • Veterans Affairs Medical Center

    Washington D.C., DC 20422

    Site contact: Rachel Denyer, MD · Rachel.Denyer@va.gov

  • Us Helping Us, People into Living, Inc.

    Washington D.C., DC

    Site contact: DeMarc Hickson, PhD · dhickson@uhupil.org

Study contacts (from the official record)

  • Amanda D Castel, MD, MPH · 202-994-8325 · acastel@gwu.edu
  • Megan O'Brien, PhD, MPH · 202-994-2034 · megan.obrien1@gwu.edu
All healthy volunteers studies in District of Columbia →
The DC Cohort Longitudinal HIV Status Neutral Study (NCT01206920) | Bored Studies